CA3129257A1 - Systeme et procedes de traitement de cellules cancereuses a champs magnetiques a polarite alternee - Google Patents
Systeme et procedes de traitement de cellules cancereuses a champs magnetiques a polarite alternee Download PDFInfo
- Publication number
- CA3129257A1 CA3129257A1 CA3129257A CA3129257A CA3129257A1 CA 3129257 A1 CA3129257 A1 CA 3129257A1 CA 3129257 A CA3129257 A CA 3129257A CA 3129257 A CA3129257 A CA 3129257A CA 3129257 A1 CA3129257 A1 CA 3129257A1
- Authority
- CA
- Canada
- Prior art keywords
- magnetic field
- body area
- target body
- cancer
- frequency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 129
- 201000011510 cancer Diseases 0.000 title claims abstract description 105
- 238000000034 method Methods 0.000 title claims abstract description 64
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 24
- 238000002560 therapeutic procedure Methods 0.000 claims description 127
- 238000011282 treatment Methods 0.000 claims description 66
- 210000001519 tissue Anatomy 0.000 claims description 50
- 230000008878 coupling Effects 0.000 claims description 14
- 238000010168 coupling process Methods 0.000 claims description 14
- 238000005859 coupling reaction Methods 0.000 claims description 14
- 230000033115 angiogenesis Effects 0.000 claims description 13
- 206010027476 Metastases Diseases 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 10
- 230000009401 metastasis Effects 0.000 claims description 10
- 238000003384 imaging method Methods 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 9
- 210000000481 breast Anatomy 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 238000001959 radiotherapy Methods 0.000 claims description 8
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 7
- 206010033128 Ovarian cancer Diseases 0.000 claims description 7
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 7
- 201000005202 lung cancer Diseases 0.000 claims description 7
- 208000020816 lung neoplasm Diseases 0.000 claims description 7
- 206010009944 Colon cancer Diseases 0.000 claims description 6
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 6
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 6
- 239000002246 antineoplastic agent Substances 0.000 claims description 6
- 208000029742 colonic neoplasm Diseases 0.000 claims description 6
- 206010038038 rectal cancer Diseases 0.000 claims description 6
- 201000001275 rectum cancer Diseases 0.000 claims description 6
- 229940041181 antineoplastic drug Drugs 0.000 claims description 5
- 201000007270 liver cancer Diseases 0.000 claims description 5
- 208000014018 liver neoplasm Diseases 0.000 claims description 5
- 208000026807 lung carcinoid tumor Diseases 0.000 claims description 5
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 5
- 201000002528 pancreatic cancer Diseases 0.000 claims description 5
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 5
- 206010006187 Breast cancer Diseases 0.000 claims description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims description 4
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
- 206010061523 Lip and/or oral cavity cancer Diseases 0.000 claims description 4
- 208000003445 Mouth Neoplasms Diseases 0.000 claims description 4
- 208000010505 Nose Neoplasms Diseases 0.000 claims description 4
- 206010060862 Prostate cancer Diseases 0.000 claims description 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 4
- 206010038389 Renal cancer Diseases 0.000 claims description 4
- 208000004337 Salivary Gland Neoplasms Diseases 0.000 claims description 4
- 206010061934 Salivary gland cancer Diseases 0.000 claims description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 4
- 206010043515 Throat cancer Diseases 0.000 claims description 4
- 238000011319 anticancer therapy Methods 0.000 claims description 4
- 230000002902 bimodal effect Effects 0.000 claims description 4
- 230000027288 circadian rhythm Effects 0.000 claims description 4
- 206010017758 gastric cancer Diseases 0.000 claims description 4
- 201000010982 kidney cancer Diseases 0.000 claims description 4
- 201000011549 stomach cancer Diseases 0.000 claims description 4
- 201000002510 thyroid cancer Diseases 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 229940044683 chemotherapy drug Drugs 0.000 claims description 3
- 238000002591 computed tomography Methods 0.000 claims description 3
- 230000036210 malignancy Effects 0.000 claims description 3
- 230000002992 thymic effect Effects 0.000 claims description 3
- 208000024363 trachea neoplasm Diseases 0.000 claims description 3
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 claims description 2
- 239000004037 angiogenesis inhibitor Substances 0.000 claims description 2
- 229940121369 angiogenesis inhibitor Drugs 0.000 claims description 2
- 238000001574 biopsy Methods 0.000 claims description 2
- 238000007705 chemical test Methods 0.000 claims description 2
- -1 immunotherapy Substances 0.000 claims description 2
- 238000009169 immunotherapy Methods 0.000 claims description 2
- 238000007431 microscopic evaluation Methods 0.000 claims description 2
- 238000010827 pathological analysis Methods 0.000 claims description 2
- 210000003800 pharynx Anatomy 0.000 claims description 2
- 230000002829 reductive effect Effects 0.000 claims description 2
- 238000002626 targeted therapy Methods 0.000 claims description 2
- 230000005672 electromagnetic field Effects 0.000 claims 5
- 238000001356 surgical procedure Methods 0.000 claims 3
- 230000002060 circadian Effects 0.000 claims 2
- 238000002595 magnetic resonance imaging Methods 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 229940124650 anti-cancer therapies Drugs 0.000 claims 1
- 238000001794 hormone therapy Methods 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 claims 1
- 210000001331 nose Anatomy 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 208000013066 thyroid gland cancer Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 174
- 230000005684 electric field Effects 0.000 description 29
- 230000008859 change Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 210000004881 tumor cell Anatomy 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 230000011278 mitosis Effects 0.000 description 6
- 108091060290 Chromatid Proteins 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 230000032823 cell division Effects 0.000 description 5
- 210000004756 chromatid Anatomy 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000021953 cytokinesis Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 102000029749 Microtubule Human genes 0.000 description 4
- 108091022875 Microtubule Proteins 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000011262 co‐therapy Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 201000001441 melanoma Diseases 0.000 description 4
- 210000004688 microtubule Anatomy 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 208000024770 Thyroid neoplasm Diseases 0.000 description 3
- 230000031016 anaphase Effects 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000016507 interphase Effects 0.000 description 3
- 230000031864 metaphase Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 230000031877 prophase Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 230000016853 telophase Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000050051 Chelone glabra Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004718 centriole Anatomy 0.000 description 2
- 210000002230 centromere Anatomy 0.000 description 2
- 239000012829 chemotherapy agent Substances 0.000 description 2
- 201000004101 esophageal cancer Diseases 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000004565 tumor cell growth Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 1
- 206010023825 Laryngeal cancer Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 208000000728 Thymus Neoplasms Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002710 external beam radiation therapy Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000014399 negative regulation of angiogenesis Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100001068 severe skin irritation Toxicity 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000005010 torso Anatomy 0.000 description 1
- 206010044285 tracheal cancer Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/015—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on semiconductor elements having potential barriers, e.g. having a PN or PIN junction
- G02F1/017—Structures with periodic or quasi periodic potential variation, e.g. superlattices, quantum wells
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/015—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on semiconductor elements having potential barriers, e.g. having a PN or PIN junction
- G02F1/025—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on semiconductor elements having potential barriers, e.g. having a PN or PIN junction in an optical waveguide structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nonlinear Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
La présente invention concerne des systèmes et un procédé de destruction ou d'inhibition de cellules cancéreuses et d'autres cellules se divisant rapidement comprenant l'application de champs magnétiques AP ayant une fréquence de 0,5 à 500 kHz et une intensité de champ de 0,5 à 5 mT à une surface de corps cible qui comprend le cancer ou d'autres cellules se divisant rapidement.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802689P | 2019-02-07 | 2019-02-07 | |
| US62/802,685 | 2019-02-07 | ||
| US16/784,239 US11027143B2 (en) | 2020-02-06 | 2020-02-06 | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US16/784,239 | 2020-02-06 | ||
| PCT/US2020/017365 WO2020163824A1 (fr) | 2019-02-07 | 2020-02-07 | Système et procédés de traitement de cellules cancéreuses à champs magnétiques à polarité alternée |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3129257A1 true CA3129257A1 (fr) | 2020-08-13 |
Family
ID=77663214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3129257A Pending CA3129257A1 (fr) | 2019-02-07 | 2020-02-07 | Systeme et procedes de traitement de cellules cancereuses a champs magnetiques a polarite alternee |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3921024A1 (fr) |
| CA (1) | CA3129257A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11344739B2 (en) | 2019-02-07 | 2022-05-31 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US11344740B2 (en) | 2019-02-07 | 2022-05-31 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
-
2020
- 2020-02-07 EP EP20710660.0A patent/EP3921024A1/fr active Pending
- 2020-02-07 CA CA3129257A patent/CA3129257A1/fr active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11344739B2 (en) | 2019-02-07 | 2022-05-31 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US11344740B2 (en) | 2019-02-07 | 2022-05-31 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US11577089B2 (en) | 2019-02-07 | 2023-02-14 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US11583692B2 (en) | 2019-02-07 | 2023-02-21 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
| US11944837B2 (en) | 2019-02-07 | 2024-04-02 | Asha Medical, Inc. | System and methods for treating cancer cells with alternating polarity magnetic fields |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3921024A1 (fr) | 2021-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11027143B2 (en) | System and methods for treating cancer cells with alternating polarity magnetic fields | |
| US11931593B2 (en) | System and methods for treating cancer cells with alternating polarity magnetic fields | |
| TWI812157B (zh) | 用以對患者的身體部位提供磁性治療和射頻治療的治療裝置 | |
| US11944837B2 (en) | System and methods for treating cancer cells with alternating polarity magnetic fields | |
| US20200330758A1 (en) | Combination electrical and chemotherapeutic treatment of cancer | |
| US20060276858A1 (en) | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases | |
| US11517760B2 (en) | Systems and methods of treating medical conditions using arrays of planar coils configured to generate pulsed electromagnetic fields and integrated into clothing | |
| CN107281635B (zh) | 电极理疗装置和电极定位方法 | |
| US20210016101A1 (en) | Systems and Methods of Modulating Electrical Impulses in an Animal Brain Using Arrays of Planar Coils Configured to Generate Pulsed Electromagnetic Fields and Integrated into Clothing | |
| CN109432601A (zh) | 用于破坏和抑制患者体内病变组织快速生长的设备 | |
| CA3129257A1 (fr) | Systeme et procedes de traitement de cellules cancereuses a champs magnetiques a polarite alternee | |
| WO2013114156A1 (fr) | Appareil et procédé d'irradiation de tissu biologique | |
| WO2020021320A1 (fr) | Système et inducteur pour produire des effets sur une tumeur par exposition à un champ magnétique | |
| CN112007277A (zh) | 用于乳腺癌治疗的脉冲电磁场设备 | |
| Fiocchi et al. | Modelling of magnetoelectric nanoparticles for non-invasive brain stimulation: a computational study | |
| WO2022035719A1 (fr) | Système et méthodes de traitement de cellules cancéreuses avec des champs magnétiques à polarité alternée | |
| RU2799358C2 (ru) | Способы и устройства для эстетической терапии биологических структур с помощью радиочастотной и магнитной энергии | |
| EP3612270B1 (fr) | Système modulaire électromagnétique pour la régénération cellulaire | |
| Parra | Abstract# 38: Transcranial Electric Stimulation with Multiple Electrodes Can Reach Deep Brain Areas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20240206 |